Exchange: SHZ Sector: Healthcare Industry: Biotechnology
3.29% CNY22.94
America/New_York / 5 mai 2024 @ 23:31
FUNDAMENTALS | |
---|---|
MarketCap: | 12 162 mill |
EPS: | 1.110 |
P/E: | 20.67 |
Earnings Date: | May 10, 2024 |
SharesOutstanding: | 530.17 mill |
Avg Daily Volume: | 1.620 mill |
RATING 2024-04-30 |
---|
A+ |
Buy |
RATINGS | ||
---|---|---|
Rating CashFlow: | Buy | |
Return On Equity: | Buy | |
Return On Asset: | Buy | |
DE: | Buy | |
P/E: | Buy | |
Price To Book: | Buy |
QUARTER GROWTHS | ||||||
---|---|---|---|---|---|---|
4/22 | 1/23 | 2/23 | 3/23 | 4/23 | 1/24 | |
Revenue | ||||||
Gr.Profit | ||||||
Ebit | ||||||
Asset | ||||||
Debt |
PE RATIO: COMPANY / SECTOR |
---|
0.58x |
Company: PE 20.67 | sector: PE 35.84 |
PE RATIO: COMPANY / INDUSTRY |
---|
0.71x |
Company: PE 20.67 | industry: PE 29.29 |
DISCOUNTED CASH FLOW VALUE |
---|
CNY28.98 (26.34%) CNY6.04 |
Date: 2024-05-05 |
Expected Trading Range (DAY) |
---|
CNY 21.67 - 22.75 ( +/- 2.45%) |
ATR Model: 14 days |
Indicator Signals | |
---|---|
RSI 21 | |
SMA | |
Trend | |
Trend 2 | |
Trend 3 | |
MACD |
Volume Signals | |
---|---|
Price | CNY22.94 (3.29% ) |
Volume | 1.939 mill |
Avg. Vol. | 1.620 mill |
% of Avg. Vol | 119.68 % |
Signal 1: | |
Signal 2: |
0 Signals | Accuracy: 0.00% | Accuracy Buy: 0.00% | Accuracy Sell: 0.00%
Avg return buy: 0.00 % | Avg return sell: 0.00 %
$1 invested is now $1.00 or 0.00% since Coming Soon
Date | Signal | @ | Closed | % |
---|
Tibet Cheezheng Tibetan Medicine Co., Ltd. together with its subsidiaries, engages in the research, development, production, and sale of Tibetan medicine in China. It provides drug products in the areas of cardiovascular, respiratory, digestive, urinary and reproductive system, nervous system, musculoskeletal system, and gynecological disorders. The company was founded in 1995 and is based in Nyingchi, China. Tibet Cheezheng Tibetan Medicine Co., Ltd. operates as a subsidiary of Gansu Qizheng Industry Group Co., Ltd.